has been localized using phalloidin stain [Chalfie, 1995] at junctional complexes and the Tomes' process [Nishikawa and Kitamura, 1986; Nishikawa and Josephsen, 1987; Nishikawa et al., 1988] .
In many cell types, activation of the RhoA signaling pathway is associated with an increase in F-actin [Ridley and Hall, 1992; Maekawa et al., 1999] . Actin monomers associate to form F-actin filaments often detected in structures that are associated with cellular movement and alterations in shape. Sodium fluoride elevates F-actin through activation of the RhoA signaling pathway in fibroblasts as well as in ameloblasts in cultured murine teeth [Vincent and Settleman, 1999; Li et al., 2005] . When RhoA activity is limited using inhibitors of downstream ROCK (Rho kinase) such as Y-27632, the elevation of Factin in teeth treated with NaF is reduced, indicating a role of RhoA in regulation of the ameloblast cytoskeleton [Li et al., 2005] .
To test the role of RhoA in vivo, transgenic mice were generated that express dominant negative RhoA (RhoA DN ) in ameloblasts as the N19 dominant negative mutation decreases the activity of endogenous RhoA [Qiu et al., 1995] . Ameloblasts are thought to move in sliding rows in order to generate decussation patterns in enamel through effects of F-actin at junctional complexes [Nishikawa, 1990; Smith and Nanci, 1995] . The hypothesis tested was that mice that express this transgene can reveal the effects of inhibition of this signaling pathway in vivo.
Materials and Methods

Tooth Germ Cultures
First molar teeth were dissected from wild-type (WT) mice, cultured, and treated. Frozen sections were stained with phalloidin and evaluated by confocal microscopy as described [Li et al., 2005] , except that the NaF concentration was reduced to 500 M . Some teeth were preincubated with Y-27632 as previously described or with 20 M HA1077 (Sigma, Milwaukee, Wisc., USA) for 30 min prior to treatment with NaF or NaCl.
Generation of the Expression Vector and Transgenic Mice
The plasmid used previously to generate transgenic mice that express various amelogenins by ameloblasts [Gibson et al., 2007; Pugach et al., 2010] was altered by removal of the signal sequence for secretion and by insertion of the enhanced green fluorescent protein (EGFP) gene fused to the RhoA DN coding sequence from pcDNA3-EGFPR-T19N (Addgene, Cambridge, Mass., USA). The DNA sequence was verified, and the plasmid was digested to release the insert which was injected at the University of Pennsylvania Transgenic Core Facility. The 3 founder mice were mated separately to WT mice to generate 3 strains. All work was approved by the University of Pennsylvania Institutional Animal Care and Use Committee.
Molecular Analysis of Mice
Each mouse was analyzed by PCR of tail DNA using G929 [Chen et al., 2003 ] and G1108 5 TGAACAGCTCCTCGCCC-TTGCTC. Molar teeth were dissected from postnatal day 3 (PN3) mice, and RNA was isolated. First-strand cDNA was synthesized using SuperScript III reverse transcriptase (Invitrogen, Carlsbad, Calif., USA) for RT-PCR with 3 primers specific for EGFP (G1109 5 AGTCGTGCTGCTTCATGTGGT) or RhoA (G1112 5 ATC-ACCAACAATCACCAGTTTC). ␤ -Actin primers were as described [Yuan et al., 1996] .
Immunohistochemistry
Mandibles were fixed and embedded in paraffin. Sections stained for the reporter protein using anti-GFP (Abcam, Inc., Cambridge, Mass., USA) and a Vectastain ABC kit (Vector Laboratories, Burlingame, Calif., USA) indicated the localization of transgenic protein in molars. WT sections and transgenic sections lacking primary antibody served as controls.
Scanning Electron Microscopy
First molars from 8-week-old WT and transgenic mice were sectioned mesiodistally and etched for 30 s with 10% HCl to reveal decussation patterns using scanning electron microscopy (SEM). To examine molar surfaces, mandibles from 8-week-old mice were sputter coated and analyzed by SEM at 20 kV (JEOL JSM T330A; JEOL, Peabody, Mass., USA).
WT and transgenic first molar enamel thicknesses were measured in mesiodistal longitudinal sections. Sections were etched for 30 s with 10% HCl and imaged by SEM (n = 3). The enamel thickness of the distal face of the central cusp was measured at 10 locations via analysis by ImageJ [Rasband, 1997 [Rasband, -2009 . The asterisk indicates a significant difference compared to the WT (p ! 0.05) using ANOVA.
Results
WT molar teeth from PN1.5-2 mice were dissected and incubated in the presence of NaF or NaCl as had been done previously [Li et al., 2005] but with 1/8 of the concentration of halide. Pretreatment with the previously tested ROCK inhibitor Y-27632 or with the slightly more specific ROCK inhibitor HA1077 [Davies et al., 2000] indicated that inhibition of ROCK abolished F-actin elevation by fluoride using either reagent as measured by confocal microscopy ( fig. 1 ) .
In order to test the in vivo importance of this pathway, a plasmid was generated for the expression of a fused EGFP-RhoA DN protein under the control of amelogenin gene regulatory sequences. Three strains of transgenic mice were generated, i.e. TgAmelxEGFP-RhoA DN -2, TgAmelxEGFP-RhoA DN -8, and TgAmelxEGFPRhoA DN -13, and each transgenic mouse was genotyped by PCR of tail DNA.
RNA analysis by RT-PCR indicated molar expression of EGFP and RhoA DN by the transgenic mice ( fig. 2 a) , which is in agreement with the results of Western blot using anti-GFP or anti-RhoA antibodies (not shown). In addition, Western blot analysis showed that TgEGFPRhoA DN -13 had the highest level of expression, strain TgEGFP-RhoA DN -8 had the lowest, strain TgEGFPRhoA DN -2 was intermediate, and in strain TgEGFPRhoA DN -13 transgenic and endogenous RhoA levels were similar.
Phalloidin staining and histological analysis of ameloblasts from PN2-3 mice did not reveal an obvious morphological anomaly in transgenic teeth (not shown). Expression of the transgene was apparent at PN2 (not shown) and elevated at PN3 ( fig. 2 b, c) . Controls lacking primary antibody or WT sections were negative for stain. We hypothesized that there could be an effect of RhoA DN in molars from slightly older mice, but an initial analysis of the decussation patterns of sectioned and etched molar teeth did not indicate an obvious anomaly in strain TgEGFP-RhoA DN -13 (high expressor; fig. 3 a, b) or either of the other strains (data not shown). SEM analysis of the transgenic molars revealed similar enamel pitting defects in all 3 strains at ages 2, 4 and 8 weeks, and a typical view is shown for strain TgEGFP-RhoA DN -8 (low expressor; fig. 3 d) compared to the WT ( fig. 3 c) . In addition, the molar enamel layer was significantly thinner in all 3 transgenic strains ( fig. 3 e) .
Discussion
Previously we showed that the Y-27632 inhibitor of the RhoA/ROCK pathway interferes with the ability of 4 m M NaF to double F-actin in ameloblasts using tooth organ cultures. Because reported effects of NaF include ameloblast-specific alterations [Smith et al., 1993; Robinson et al., 2004] , these experiments were repeated with an additional ROCK inhibitor and lower levels of NaF and NaCl, and the results were similar to those at the higher concentration of NaF. We therefore hypothesized that Rho/ROCK may also be involved in the ameloblast shape changes that occur normally during the ameloblast developmental stages.
Three lines of transgenic mice are described that express a transgenic EGFP-RhoA DN fusion protein in ameloblasts during the secretory stage of enamel development. The transgenic protein was detected in ameloblasts at PN2, a time when phalloidin staining of ameloblasts for the F-actin component of the cytoskeleton revealed a normal staining pattern. Amelogenin proteins are expressed normally until at least PN4 in these transgenic mice (not shown). Transgene expression is elevated at PN3 and PN4, and using SEM of 2-, 4-, and 8-week-old molars, a pitting defect was observed in the molar cusp enamel at all ages analyzed and in all transgenic strains regardless of the level of transgene expression. The 2-week-old mice still had a layer of mucosa covering the molars, so the defect is considered to be developmental rather than due to attrition because of mastication. Although in an initial analysis decussation patterns appeared to be relatively normal in defect-free areas, enamel hypoplasia was observed in molars of the 3 strains.
RhoA and ROCK mRNA levels were recently reported to be elevated in WT rat first molars at PN5 [Biz et al., 2010] , and we have observed a similar elevation in murine molars (not shown). Because the Rho dissociation inhibitor RhoGDI, which sequesters Rho to control its status, decreases shortly after birth [Hatakeyama et al., 2009] , this pathway fluctuates exactly as the ameloblast cells undergo changes in structural/functional relationships.
In conclusion, disruption of the RhoA pathway leads to hypoplastic enamel with surface defects; this is consistent with an important role for RhoA during the secretory stage. Because the Rho/ROCK pathway is elevated in the presence of sodium fluoride, RhoA signaling may be important both developmentally and in conditions in which the fluoride ion interferes with its normal activity.
